Comprehensive molecular profiling of the B7 family in gastrointestinal cancer.

B7 family has been identified as co-stimulatory or co-inhibitory molecules on T-cell response and plays an important role in tumour mortality and malignancy. In this study, the expression pattern of B7 family in gastrointestinal (GI) cancer was examined. Its upstream regulating mechanism, downstream targets and association with clinical parameters were also studied. The expression level of B7 members was analysed by FIREHOUSE. The gene mutation, DNA methylation, association with clinical parameters and downstream network of B7 members were analysed in cBioportal. The mutation frequency was analysed by Catalogue of Somatic Mutations in Cancer (COSMIC) analysis. The phylogenetic tree was constructed in MEGA7. The interaction protein domain analysis was performed by Pfam 31.0. Differential expression of B7 family molecules was detected in different kinds of GI cancer. High-frequency gene alteration was found in tumour samples. There was negative correlation of promoter methylation and mRNA expression of B7 family members in tumour samples, suggesting the epigenetic basis of B7 family gene deregulation in GI cancer. The overexpression of B7-H1 in pancreatic cancer, B7-H5 in oesophageal cancer and B7-H6 in liver cancer were significantly associated with worse overall survival. Finally, by network analysis, we identified some potential interacting proteins for B7-1/2 and B7-H1/DC. Overall, our study suggested that B7 member deregulation was strongly involved in GI cancer tumorigenesis. © 2018 John Wiley & Sons Ltd.

Citation

Qijie Zhao, Fuyan Hu, Zhangang Xiao, Mingxing Li, Xu Wu, Yueshui Zhao, Yuanlin Wu, Jianhua Yin, Ling Lin, Hanyu Zhang, Lingling Zhang, Chi Hin Cho, Jing Shen. Comprehensive molecular profiling of the B7 family in gastrointestinal cancer. Cell proliferation. 2018 Oct;51(5):e12468

Mesh Tags

Substances

PMID: 29999557

search → result